Oracle's AI Bet Drives a Sharp Divide Between Oversold Equity and Record Credit Fears
Published on 07/18/2026 at 15:24 | Redaktion boerse-global.de
Oracle has become a study in contradiction. Its stock is deeply oversold, yet the cost of insuring the company's debt has never been higher. The two markets are pricing in wildly different scenarios for the same AI build-out, and each is sending a clear warning.
The equity side tells a story of sheer exhaustion. On Friday, shares closed at €110.56, up 1.79% on the day but still down 10.29% for the week. The monthly drop stands at 30.75%, while year-to-date losses have swelled to 33.48% and the 12-month decline reaches 48.48%. Since hitting a record high of €280.70 on September 10, 2025, the stock has shed 60.61% of its value. During Friday's session, Oracle touched a fresh 52-week low of €105.10 before staging a modest recovery. The 14-day relative strength index sits at 29.0, deep in oversold territory, and the annualized 30-day volatility of 47.23% underscores just how violently the shares are swinging.
While equity investors capitulate, the credit market is flashing an even more alarming signal. Credit default swaps on Oracle jumped roughly 10 basis points on Friday to close at 198.23 points — the highest reading ever recorded by ICE Data Services. The surge in the cost of default protection reflects mounting unease over Oracle's aggressive cash burn and the ultimate profitability of its AI infrastructure push. A recent report from the New York Times, published July 17, framed Oracle as a bellwether for a broader credit-market worry: can tech giants finance their AI expansion through debt without overstretching their balance sheets?
That question is becoming urgent. Oracle's management has penciled in roughly $70 billion in net capital expenditure for fiscal 2027 alone. In fiscal 2026, the company already added $43 billion in new debt and raised $5 billion through an equity offering. For the current fiscal year, Oracle plans to raise another $40 billion — most of it via a $20 billion at-the-market equity sale. Remarkably, the company intends to avoid new bond issuances in calendar 2026. Total debt has ballooned to approximately $167 billion, while total liabilities have jumped 48% to $218.7 billion.
Should investors sell immediately? Or is it worth buying Oracle?
The broader bond market backdrop offers little comfort. Amazon placed a $25 billion bond package in July, and the U.S. high-yield market absorbed $31.9 billion in fresh AI-related issuance through July 8 — almost entirely earmarked for data center construction. But Oracle's elevated CDS suggests investors see it as the most exposed among the big spenders, in part because its customer base is unusually concentrated among a handful of large AI clients.
Against this nervous backdrop, the stock's technical oversold condition has done little to attract bargain hunters. The options market is bracing for more turbulence: implied volatility sits in the 95th percentile of its one-year range. Analysts remain far more optimistic than the market, with a consensus price target of $268.79 (roughly €256) — more than double the current share price. On TipRanks, Oracle carries a Strong Buy rating based on 28 buy recommendations and five holds over the past three months. Yet the target range is enormous: Guggenheim sees $400 while Stephens & Co. projects just $164, a spread that reveals deep uncertainty about how the AI infrastructure bet will play out.
Adding to the unease, a new Chinese AI model has emerged that could seriously challenge offerings from companies like OpenAI. For Oracle, whose fortunes are tightly tied to its biggest AI tenants, any disruption in that competitive landscape amplifies the risk that contracted revenue may not materialize as expected.
Oracle at a turning point? This analysis reveals what investors need to know now.
The company continues to pay a quarterly dividend of $0.50 per share, with the next ex-date set for July 10, 2026 — a modest gesture of continuity while the narrative around the stock gets rewritten. But the real test lies ahead. Oracle's ability to convert its massive backlog into cash, and the credit market's reaction to its next round of capital raises — particularly the planned $20 billion equity sale — will determine whether the current disconnect between oversold equity and record-high credit risk resolves in a recovery or a deeper reckoning.
Ad
Oracle Stock: New Analysis - 18 July
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
